Valsartan Recall May Affect Up to 2 Million Patients
The U.S. Food and Drug Administration (FDA) recently issued a recall for medications containing an ingredient known as valsartan. It is estimated that as many as 2 million people have received recall letters for medications with valsartan, which has been linked to several forms of cancer affecting the digestive system.
What’s the Problem?
An estimated one in three people in the U.S. have high blood pressure, and many of them take medications that contain valsartan. But valsartan is also in drugs used to treat people suffering from heart failure, as well as people who have recently survived a heart attack. The ingredient is designed to help relax the blood vessels, making it easier for blood to circulate.
However, an impurity found in the manufacturing process of drugs containing valsartan may have put people at an increased risk for cancer. N-nitrodimethylamine (NDMA) – a probable human carcinogen – was found in pills containing valsartan. These pills were produced at a Chinese facility.
It appears that these pills have been manufactured for several years, putting millions of people at risk as a result. In July 2018 the FDA issued a recall for products containing valsartan sold by several pharmaceutical companies.
What to Do Next
If you received an FDA recall letter, that means you probably have, or have taken, medications containing tainted valsartan. This FDA website provides an extensive list of recalled medications, including the manufacturer, product name, NDC (National Drug Code) code number, lot number and expiration date.
Unfortunately, there are very few warning signs your body will give you that indicate a problem with a drug containing valsartan. If you notice anything abnormal regarding your health, please talk to a doctor immediately.
If you have taken a medication containing valsartan since 2012 and were later diagnosed with kidney, liver, stomach or pancreatic cancer, Baron & Budd may be able to help. Please give us a call at 866-723-1890 or contact us online for more information.